Newsroom
November 5, 2021
UT Health San Antonio offers COVID-19 Pfizer-BioNTech pediatric vaccine for children 5 to 11 years old. Convenient appointments can be scheduled online for both children and adults.
November 5, 2021
For Sudha Seshadri, MD, professor of neurology and the founding director of the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, fighting for brain health is personal.
November 5, 2021
A large, multi-site study funded by the National Institutes of Health aims to test the effectiveness of three existing drugs, including controversial ivermectin, to treat the symptoms of COVID-19. Known as ACTIV-6, the study is now underway at UT Health San Antonio.
November 4, 2021
This quick and helpful Q&A video speaks to vaccine symptoms, the importance of booster shots and other timely topics.
November 3, 2021
The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) has endorsed the recommendation that children 5 to 11 years old be vaccinated against COVID-19 with the Pfizer-BioNTech pediatric vaccine.
October 26, 2021
Lindsay Fry is a breast cancer survivor who was first diagnosed in 2019. Her treatment regimen of surgery, radiation and chemotherapy began in fall 2019. Shortly after completing her treatment, Fry became the first participant in a new clinical trial at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) that aims to help breast cancer survivors regain their energy and remain cancer free.
